KNTE
Kinnate Biopharma Inc.
Director and 10% owner James B. Tananbaum bought $20.0M of Kinnate Biopharma Inc.
Bought$20,000,000
$20.00Price
1,000,000Shares
−114%Stake
What KNTE did for a copier
Prices for KNTE after this filing aren't in yet.
James B. Tananbaum's record
6 other buys with 3 months of prices since 2023: on average +87.2% against the S&P 500, and 3 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Dec 3. Filed Fri, Dec 4. Not investment advice.